Literature DB >> 20347666

Superficial mycoses in immunodepressed patients (AIDS).

Marcia Ramos-E-Silva1, Cíntia Maria Oliveira Lima, Regina Casz Schechtman, Beatriz Moritz Trope, Sueli Carneiro.   

Abstract

HIV infection has the capacity to distort the epidemiology and clinical course of infectious diseases, producing atypical manifestations and changing diagnoses. Superficial fungal infections are frequent in HIV-positive/AIDS patients and are no exception. These infections are frequently different in immunodepressed patients (AIDS), with a modified course or exacerbations. This chapter discusses the diagnosis and treatment of superficial mycoses in HIV patients, including cutaneous alterations caused by Candida, dematiaceous fungi agents of phaeohyphomycosis, Malassezia spp, dermatophyte, and filamentous nondermatophyte fungi. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20347666     DOI： 10.1016/j.clindermatol.2009.12.008

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


  10 in total

1.  IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans.

Authors:  Shinji Kagami; Heather L Rizzo; Stephen E Kurtz; Lloyd S Miller; Andrew Blauvelt
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

Review 2.  Histopathologic diagnosis of fungal infections in the 21st century.

Authors:  Jeannette Guarner; Mary E Brandt
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 3.  Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.

Authors:  Anne Puel; Sophie Cypowyj; László Maródi; Laurent Abel; Capucine Picard; Jean-Laurent Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-12

Review 4.  Immunity to infection in IL-17-deficient mice and humans.

Authors:  Sophie Cypowyj; Capucine Picard; László Maródi; Jean-Laurent Casanova; Anne Puel
Journal:  Eur J Immunol       Date:  2012-09       Impact factor: 5.532

5.  Candida albicans delays HIV-1 replication in macrophages.

Authors:  Christian Rodriguez Rodrigues; Federico Remes Lenicov; Carolina Jancic; Juan Sabatté; Mercedes Cabrini; Ana Ceballos; Antonela Merlotti; Heidi Gonzalez; Matías Ostrowski; Jorge Geffner
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

6.  Dermatophytes activate skin keratinocytes via mitogen-activated protein kinase signaling and induce immune responses.

Authors:  Rebecca R Achterman; David L Moyes; Selvam Thavaraj; Adam R Smith; Kris M Blair; Theodore C White; Julian R Naglik
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

7.  Effective Single Photodynamic Treatment of ex Vivo Onychomycosis Using a Multifunctional Porphyrin Photosensitizer and Green Light.

Authors:  Chelsea den Hollander; Jasper Visser; Ellen de Haas; Luca Incrocci; Threes Smijs
Journal:  J Fungi (Basel)       Date:  2015-07-27

Review 8.  Majocchi's granuloma: current perspectives.

Authors:  Hazal Boral; Murat Durdu; Macit Ilkit
Journal:  Infect Drug Resist       Date:  2018-05-22       Impact factor: 4.003

9.  TRAF1 suppresses antifungal immunity through CXCL1-mediated neutrophil recruitment during Candida albicans intradermal infection.

Authors:  Wenjuan Bai; Qingqing Wang; Zihou Deng; Tiantian Li; Hui Xiao; Zhiyuan Wu
Journal:  Cell Commun Signal       Date:  2020-02-24       Impact factor: 5.712

10.  Prevalence of Malassezia species on the skin of HIV-seropositive patients.

Authors:  Paweł Krzyściak; Zofia Bakuła; Agnieszka Gniadek; Aleksander Garlicki; Mikołaj Tarnowski; Michał Wichowski; Tomasz Jagielski
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.